Advances and limitations of drug delivery systems formulated as eye drops

Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana

doi:10.1016/j.jconrel.2020.01.057

journal article Open Access May 01, 2020

Advances and limitations of drug delivery systems formulated as eye drops

Clotilde Jumelle Shima Gholizadeh Nasim Annabi

Reza Dana

Journal of Controlled Release Vol. 321 pp. 1-22 · Elsevier BV

View at Publisher Save 10.1016/j.jconrel.2020.01.057

Topics

No keywords indexed for this article. Browse by subject →

References

152

[1]

Awwad "Principles of pharmacology in the eye" Br. J. Pharmacol. (2017) 10.1111/bph.14024

[2]

Gause "Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses" Adv. Colloid Interf. Sci. (2016) 10.1016/j.cis.2015.08.002

[3]

Ocular drug delivery

Deepta Ghate, Henry F Edelhauser

Expert Opinion on Drug Delivery 2006 10.1517/17425247.3.2.275

[4]

Imperiale "Polymer-based carriers for ophthalmic drug delivery" J. Control. Release (2018) 10.1016/j.jconrel.2018.06.031

[5]

Worakul "Ocular pharmacokinetics/pharmacodynamics" Eur. J. Pharm. Biopharm. (1997) 10.1016/s0939-6411(97)00064-7

[6]

Agrahari "A comprehensive insight on ocular pharmacokinetics" Drug Deliv. Transl. Res. (2016) 10.1007/s13346-016-0339-2

[7]

(1984)

[8]

Mitra "Drug delivery to the eye" (2005) 10.1016/s1569-2590(05)10012-3

[9]

Dastjerdi "Corneal penetration of topical and Subconjunctival Bevacizumab" Invest. Ophthalmol. Vis. Sci. (2011) 10.1167/iovs.11-7871

[10]

Zhang "Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition" Drug Metab. Dispos. (2008) 10.1124/dmd.108.021121

[11]

Kölln "mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs" J. Ocul. Pharmacol. Ther. (2012) 10.1089/jop.2011.0124

[12]

Karla "Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells" Curr. Eye Res. (2009) 10.1080/02713680802518251

[13]

Ahmed "Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea" J. Pharm. Sci. (1987) 10.1002/jps.2600760802

[14]

Urtti "Challenges and obstacles of ocular pharmacokinetics and drug delivery" Adv. Drug Deliv. Rev. (2006) 10.1016/j.addr.2006.07.027

[15]

Patel "Ocular drug delivery systems: An overview" World J. Pharmacol. (2013) 10.5497/wjp.v2.i2.47

[16]

Ludwig "The use of mucoadhesive polymers in ocular drug delivery" Adv. Drug Deliv. Rev. (2005) 10.1016/j.addr.2005.07.005

[17]

Bayat "A reversible thermoresponsive sealant for temporary closure of ocular trauma" Sci. Transl. Med. (2017) 10.1126/scitranslmed.aan3879

[18]

Sun "A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation" Drug Des. Dev. Ther. (2018) 10.2147/dddt.s153405

[19]

Patel "Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability" Drug Deliv. (2016) 10.1080/10717544.2016.1223225

[20]

Qian "Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide" Drug Dev. Ind. Pharm. (2010) 10.3109/03639041003801893

[21]

Zeng "Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: in vitro characterization, in vivo pharmacokinetics and pharmacodynamics study" Life Sci. (2018) 10.1016/j.lfs.2018.09.050

[22]

Mansour "Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels" Drug Dev. Ind. Pharm. (2008) 10.1080/03639040801926030

[23]

Hsiue "Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide" Biomaterials (2002) 10.1016/s0142-9612(01)00127-2

[24]

Zhu "A novel thermo-sensitive hydrogel-based on poly(N-isopropylacrylamide)/hyaluronic acid of ketoconazole for ophthalmic delivery" Artif. Cells Nanomed. Biotechnol. (2018) 10.1080/21691401.2017.1368024

[25]

Wu "Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels" Int. J. Nanomedicine (2013)

[26]

Miyazaki "In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride" Int. J. Pharm. (2001) 10.1016/s0378-5173(01)00825-0

[27]

Chen "Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation" J. Biomater. Appl. (2012) 10.1177/0885328211406563

[28]

In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery

Yuanhui Song, Nobuhiro Nagai, Saaya Saijo et al.

Materials Science and Engineering: C 2018 10.1016/j.msec.2018.02.022

[29]

Cheng "Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment" Carbohydr. Polym. (2016) 10.1016/j.carbpol.2016.02.080

[30]

Wu "Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin" Yakugaku Zasshi (2007) 10.1248/yakushi.127.183

[31]

Wu "Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery" Int. J. Pharm. (2011) 10.1016/j.ijpharm.2011.03.007

[32]

Sultana "Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model" Pharm. Dev. Technol. (2006) 10.1080/10837450600767698

[33]

Dubey "Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma" Int. J. Pharm. Investig. (2014) 10.4103/2230-973x.138340

[34]

Gupta "Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate" Sci. Pharm. (2010) 10.3797/scipharm.1001-06

[35]

El-Laithy "Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation" Arch. Pharm. Res. (2011) 10.1007/s12272-011-1011-5

[36]

Kesavan "Therapeutic effectiveness in the treatment of experimental bacterial keratitis with ion-activated mucoadhesive hydrogel" Ocul. Immunol. Inflamm. (2015) 10.3109/09273948.2015.1005238

[37]

Díaz-Tomé "Ophthalmic econazole hydrogels for the treatment of fungal keratitis" J. Pharm. Sci. (2018) 10.1016/j.xphs.2017.12.028

[38]

Liu "Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin" Int. J. Pharm. (2006) 10.1016/j.ijpharm.2006.01.029

[39]

Liu "In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery" AAPS PharmSciTech (2010) 10.1208/s12249-010-9413-0

[40]

Lin "In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine" Biomacromolecules (2004) 10.1021/bm0496965

[41]

Deshmukh "In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system" Pharm. Dev. Technol. (2013) 10.3109/10837450.2011.644297

[42]

Aqil "An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention" J. Pharm. Bioallied Sci. (2015) 10.4103/0975-7406.149810

[43]

Cao "Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery" J. Control. Release (2007) 10.1016/j.jconrel.2007.05.009

[44]

Thermoresponsive Polymers for Biomedical Applications

Mark A. Ward, Theoni K. Georgiou

Polymers 2011 10.3390/polym3031215

[45]

Hacker "Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers" Biomacromolecules (2008) 10.1021/bm8000414

[46]

Sponchioni "Thermo-responsive polymers: applications of smart materials in drug delivery and tissue engineering" Mater. Sci. Eng. C Mater. Biol. Appl. (2019) 10.1016/j.msec.2019.04.069

[47]

CORNEAL TEMPERATURE IN NORMAL SUBJECTS AND ARTERIAL OCCLUSIVE DISEASE

IVAR HØRVEN

Acta Ophthalmologica 1975 10.1111/j.1755-3768.1975.tb00404.x

[48]

Girardin "Relationship between corneal temperature and finger temperature" Arch. Ophthalmol. (1999) 10.1001/archopht.117.2.166

[49]

Almeida "Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview" Expert Opin. Drug Deliv. (2013) 10.1517/17425247.2013.796360

[50]

Edsman "Rheological evaluation of poloxamer as an in situ gel for ophthalmic use" Eur. J. Pharm. Sci. (1998) 10.1016/s0928-0987(97)00075-4

Showing 50 of 152 references

Metrics

356

Citations

152

References

Details

Published: May 01, 2020
Vol/Issue: 321
Pages: 1-22
License: View

Authors

Funding

National Institutes of Health

U.S. Department of Defense

Research to Prevent Blindness

Cite This Article

Clotilde Jumelle, Shima Gholizadeh, Nasim Annabi, et al. (2020). Advances and limitations of drug delivery systems formulated as eye drops. Journal of Controlled Release, 321, 1-22. https://doi.org/10.1016/j.jconrel.2020.01.057

Advances and limitations of drug delivery systems formulated as eye drops

You May Also Like